Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Intrepid Potash Reports Medical Leave Of Absence For Executive Chairman And CEO Bob Jornayvaz; Co-founder Hugh Harvey Rejoins Board

Author: Benzinga Newsdesk | April 17, 2024 05:38pm

Intrepid granted Bob Jornayvaz a temporary medical leave of absence, effective immediately, as he recovers from his previously announced injury.In connection with Mr. Jornayvaz's leave of absence, the Board has appointed Matt Preston, Intrepid's current Chief Financial Officer, as acting principal executive officer and announced that Intrepid's co-founder, Hugh Harvey, has been appointed as a Class III Director. The Board has also temporarily delegated all responsibilities of the Chairman of the Board to Barth Whitham, Intrepid's Lead Director.

Posted In: IPI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist